Chlorhexidine gluconate - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What are the generic drug sources for chlorhexidine gluconate and what is the scope of patent protection?
Chlorhexidine gluconate
is the generic ingredient in twenty-eight branded drugs marketed by Xttrium, Sage Prods, Medline Industries, Akorn, Bajaj, Lyne, Pharm Assoc, Wockhardt Bio Ag, Sunstar Americas, 3M, Colgate Palmolive Co, Colgate-palmolive Co, Soapco, Ecolab, Molnlycke Hlth, J And J, Matrix Medcl, Griffen, Becton Dickinson, Kendall Il, Carefusion 2200, Dexcel Pharma, 3m Health Care, Becton Dickinson Co, and Prof Dspls, and is included in thirty-six NDAs. There are eleven patents protecting this compound. Additional information is available in the individual branded drug profile pages.Chlorhexidine gluconate has three patent family members in one country.
There are twenty-seven drug master file entries for chlorhexidine gluconate. Forty-nine suppliers are listed for this compound.
Summary for chlorhexidine gluconate
International Patents: | 3 |
US Patents: | 11 |
Tradenames: | 28 |
Applicants: | 25 |
NDAs: | 36 |
Drug Master File Entries: | 27 |
Finished Product Suppliers / Packagers: | 49 |
Raw Ingredient (Bulk) Api Vendors: | 40 |
Clinical Trials: | 150 |
Patent Applications: | 6,486 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for chlorhexidine gluconate |
Drug Sales Revenues: | Drug sales revenues for chlorhexidine gluconate |
What excipients (inactive ingredients) are in chlorhexidine gluconate? | chlorhexidine gluconate excipients list |
DailyMed Link: | chlorhexidine gluconate at DailyMed |
Recent Clinical Trials for chlorhexidine gluconate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Iowa | Phase 4 |
Gustavo Avila-Ortiz DDS, MS, PhD | Phase 4 |
Osteology Foundation | Phase 4 |
Pharmacology for chlorhexidine gluconate
Physiological Effect | Decreased Cell Wall Integrity |
Medical Subject Heading (MeSH) Categories for chlorhexidine gluconate
US Patents and Regulatory Information for chlorhexidine gluconate
Expired US Patents for chlorhexidine gluconate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Molnlycke Hlth | HIBICLENS | chlorhexidine gluconate | SOLUTION;TOPICAL | 017768-001 | Approved Prior to Jan 1, 1982 | See Plans and Pricing | See Plans and Pricing |
Dexcel Pharma | PERIOCHIP | chlorhexidine gluconate | TABLET;DENTAL | 020774-001 | May 15, 1998 | See Plans and Pricing | See Plans and Pricing |
Molnlycke Hlth | HIBICLENS | chlorhexidine gluconate | SPONGE;TOPICAL | 018423-001 | Approved Prior to Jan 1, 1982 | See Plans and Pricing | See Plans and Pricing |
Dexcel Pharma | PERIOCHIP | chlorhexidine gluconate | TABLET;DENTAL | 020774-001 | May 15, 1998 | See Plans and Pricing | See Plans and Pricing |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for chlorhexidine gluconate
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2551688 | DEBARBOUILLETTE NON TISSEE AMELIOREE (IMPROVED NON-WOVEN WASH CLOTH) | See Plans and Pricing |
Canada | 2467150 | DISPOSITIF D'ADMINISTRATION DE DESINFECTANT ET METHODE DE DESINFECTION SANS ALCOOL (DISINFECTANT DELIVERY SYSTEM AND METHOD OF PROVIDING ALCOHOL-FREE DISINFECTION) | See Plans and Pricing |
Canada | 2467155 | DISPOSITIF D'ADMINISTRATION DE DESINFECTANT ET METHODE DE DESINFECTION SANS ALCOOL (DISINFECTANT DELIVERY SYSTEM AND METHOD OF PROVIDING ALCOHOL-FREE DISINFECTION) | See Plans and Pricing |
>Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:






Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.